AmerisourceBergen sees its sales leap on its new Walgreens biz; Former Roche campus could become biotech park;

> AmerisourceBergen reported that for its first quarter ended Dec. 31, revenues in its pharmaceutical distribution unit were up 39% to $28.6 billion, in large part due to new business from a deal negotiated last year to handle the branded drug business for Walgreens. Release

> Regis Technologies, a Chicago-area company that provides synthesis, separations and manufacturing services to biopharma, said that its plant recently passed an FDA audit without receiving any Form 483 observations. Release

> One proposed plan for a former Roche ($RHHBY) campus in New Jersey is aimed at attracting a biotech client. Story

> The FDA has given India's Aurobindo Pharma approval to manufacture and market repaglinide tablets, a generic of Novo Nordisk's ($NVO) Prandin. Story

And Finally...  Unichem's Indian plant in Ghaziabad will manufacture a generic of GD Searle's anti-infection medication Flagyl after getting U.S. FDA approval. Report